Breast cancer detection with (99m)-Tc-sestamibi scintigraphy, mammography, and fine-needle aspiration cytology: Comparative study in 64 surgically treated patients

Annals of Surgical Oncology

Volumn 6, Issue 6, 1999, Pages 568-571

  Lumachi, Franco ^a   Marzola, Maria Cristina ^a   Zucchetta, Pietro ^a   Polistina, Francesco ^a   Cagnato, Patrizia ^b   Favia, Gennaro ^a   Bui, Franco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Abano Terme Hospital   (Italy)

Author keywords

(99m) Tc sestamibi; Breast cancer; FNAB; Mammography; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; SCINTIMAMMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0032843804     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0568-4     Document Type: Article

References (20)

1. Fiorica JV. Breast cancer. In: Leppert PC, Howard FM eds. Primary care for women. Philadelphia: Lippincot-Raven, 1997:198-202.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996;46:5-27.
3. Flanagan DA, Gladding SB, Lovell FR. Can scintimammography reduce "unnecessary" biopsies? Am Surg 1998:64:670-2.
4. Kopans DB. The positive predictive value of mammography. Am J Radiol 1992;158:521-6.
5. Dierks DB, Katy B. Lawsuits for failure to diagnose breast cancer: tumor biology in causation and risk management strategies. Surg Oncol North Am 1994;3:125-39.
6. McKenna R. The abnormal mammogram. Radiographic findings, diagnostic options, pathology and stage of cancer diagnosis. Cancer 1994;74:244-55.
7. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at the screening mammography. Radiology 1992;184:613-7.
8. Villanueva-Meyer J, Leonard MH Jr, Briscoe E, Cesani F, Ali SA, Rhoden S, Hove M, Cown D. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996; 37:926-30.
9. Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996;172:483-6.
10. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxy-isobutylisonitsile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-6.
11. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Technetium-99m-sestamibi prone Scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-65.
12. Waxman AD, Ramanna L, Memsic LD. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
13. Aigner RM, Fueger GF. First experience with technetium-99m furifosmin as tumour-seeking agent in breast cancer and recurrent ovarian cancer. Eur J Nucl Med 1997;24:1167-70.
14. Ambrus E, Rajtar M, Ormandi K, Toszegi A, Lang J, Pavics L, Cserenay L. Value of 99m-TcMIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Anticancer Res 1997;17:1599-605.
15. Scopinaro F, Schillaci O, Ussof W, et al. A three center study on the diagnostic accuracy of 99mTc-MIBl Scintimammography. Anticancer Res 1997;17:1631-4.
16. Uriate I, Carril JM, Quirce R, et al. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile Scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 1998;25:491-6.
17. 99mTc-MIBI Scintimammography in the diagnosis of non-palpable breast lesions in relation to mammographie probability of malignancy. Anticancer Res 1997;17: 1677-82.
18. Staren ED. Ultrasound-guided biopsy of nonpalpable breast masses by surgeons. Ann Surg Oncol 1996;3:476-82.
19. Cross MJ, Evans WP, Peters GN, Cheek JH, Jones RC, Krakos P. Stereotactic breast biopsy as an alternative to open excisional biopsy. Ann Surg Oncol 1995;2:195-200.
20. Cutrone JA, Yospur LS, Khalkhali I, et al. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med 1998;39:449-53.